| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/01/2023 | 180.61% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
| 08/29/2022 | 180.61% | HC Wainwright & Co. | $7 → $5.5 | Maintains | Buy |
| 08/16/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 08/11/2022 | 22.45% | B. Riley Securities | $6 → $2.4 | Downgrades | Buy → Neutral |
| 06/07/2022 | 257.14% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 05/13/2022 | 206.12% | B. Riley Securities | $8 → $6 | Maintains | Buy |
| 04/18/2022 | 308.16% | HC Wainwright & Co. | $12 → $8 | Maintains | Buy |
| 03/10/2022 | 308.16% | B. Riley Securities | $16 → $8 | Maintains | Buy |
| 03/08/2022 | 257.14% | Roth Capital | → $7 | Initiates Coverage On | → Buy |
| 08/04/2021 | 512.24% | HC Wainwright & Co. | $11 → $12 | Maintains | Buy |
| 05/10/2021 | 461.22% | HC Wainwright & Co. | $16 → $11 | Maintains | Buy |
| 03/16/2021 | 716.33% | HC Wainwright & Co. | $7 → $16 | Maintains | Buy |
| 08/18/2020 | 257.14% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 10/16/2019 | 206.12% | Oppenheimer | → $6 | Initiates Coverage On | → Outperform |
| 02/14/2019 | 257.14% | B. Riley Securities | → $7 | Initiates Coverage On | → Buy |
What is the target price for ChromaDex (CDXC)?
The latest price target for ChromaDex (NASDAQ: CDXC) was reported by HC Wainwright & Co. on February 1, 2023. The analyst firm set a price target for $5.50 expecting CDXC to rise to within 12 months (a possible 180.61% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ChromaDex (CDXC)?
The latest analyst rating for ChromaDex (NASDAQ: CDXC) was provided by HC Wainwright & Co., and ChromaDex reiterated their buy rating.
When is the next analyst rating going to be posted or updated for ChromaDex (CDXC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ChromaDex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ChromaDex was filed on February 1, 2023 so you should expect the next rating to be made available sometime around February 1, 2024.
Is the Analyst Rating ChromaDex (CDXC) correct?
While ratings are subjective and will change, the latest ChromaDex (CDXC) rating was a reiterated with a price target of $0.00 to $5.50. The current price ChromaDex (CDXC) is trading at is $1.96, which is within the analyst's predicted range.
